NASDAQ

Rapport Therapeutics, Inc. (RAPP)

♥ 634 Thanks from members

Live price chart, market sentiment, and community perspectives for Rapport Therapeutics, Inc. (NASDAQ: RAPP).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Rapport Therapeutics TeamLeadership: Abraham C. Hecht (CEO)Holder: Arch Venture PartnersHolder: Fidelity Management and ResearchPrecision neurology drugsTargeted central nervous system therapeutics#RAPP stock#Rapport Therapeutics#precision neurology#CNS drug developer#biotech IPO